摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-hydroxy-1-[4-oxo-4-(4-fluorophenyl)butyl]-4-[3-(trifluoromethyl)phenyl]-4-silapiperidinium chloride | 1219827-26-5

中文名称
——
中文别名
——
英文名称
4-hydroxy-1-[4-oxo-4-(4-fluorophenyl)butyl]-4-[3-(trifluoromethyl)phenyl]-4-silapiperidinium chloride
英文别名
1-(4-Fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]-1,4-azasilinan-1-yl]butan-1-one;hydrochloride
4-hydroxy-1-[4-oxo-4-(4-fluorophenyl)butyl]-4-[3-(trifluoromethyl)phenyl]-4-silapiperidinium chloride化学式
CAS
1219827-26-5
化学式
C21H23F4NO2Si*ClH
mdl
——
分子量
461.959
InChiKey
NRVVRBWNQUCWTH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.39
  • 重原子数:
    30
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    7

反应信息

  • 作为产物:
    描述:
    4-[3-(trifluoromethyl)phenyl]-1-{3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl}-4-(2,4,6-trimethoxyphenyl)-4-silapiperidine 在 盐酸 作用下, 以 丙酮 为溶剂, 反应 3.0h, 以74%的产率得到4-hydroxy-1-[4-oxo-4-(4-fluorophenyl)butyl]-4-[3-(trifluoromethyl)phenyl]-4-silapiperidinium chloride
    参考文献:
    名称:
    Sila-Trifluperidol, a Silicon Analogue of the Dopamine (D2) Receptor Antagonist Trifluperidol: Synthesis and Pharmacological Characterization
    摘要:
    Trifluperidol (2a) is a dopamine (1)2) receptor antagonist of the butyrophenone type. Carbon/silicon exchange (sila-substitution) in the 4-position of the piperidine ring of 2a (R3COH --> R3SiOH) results in sila-trifluperidol (2b). The silanol 21) was synthesized in a multistep synthesis, starting from triethoxy(vinyl)silane, and was isolated as the hydrochloride 2b.HCl. Compound 2b" HC1 was structurally characterized by single-crystal X-ray diffraction and solution NMR spectroscopy, and the stability of the silanol 2b in aqueous solutions at different pH values was studied by ESI-MS experiments. In addition, the pharmacological profiles of the C/Si analogues trifluperidol (2a) and sila-trifluperidol (2b) and of the related compounds haloperidol (la) and sila-haloperidol (lb) were studied in functional receptor assays at human dopamine DI and D, receptors. Sila-substitution of la ( lb) and 2a ( 2b) affects the pharmacological properties significantly.
    DOI:
    10.1021/om901011t
点击查看最新优质反应信息

文献信息

  • Sila-Trifluperidol, a Silicon Analogue of the Dopamine (D<sub>2</sub>) Receptor Antagonist Trifluperidol: Synthesis and Pharmacological Characterization
    作者:Reinhold Tacke、Binh Nguyen、Christian Burschka、W. Peter Lippert、Alexandra Hamacher、Christian Urban、Matthias U. Kassack
    DOI:10.1021/om901011t
    日期:2010.4.12
    Trifluperidol (2a) is a dopamine (1)2) receptor antagonist of the butyrophenone type. Carbon/silicon exchange (sila-substitution) in the 4-position of the piperidine ring of 2a (R3COH --> R3SiOH) results in sila-trifluperidol (2b). The silanol 21) was synthesized in a multistep synthesis, starting from triethoxy(vinyl)silane, and was isolated as the hydrochloride 2b.HCl. Compound 2b" HC1 was structurally characterized by single-crystal X-ray diffraction and solution NMR spectroscopy, and the stability of the silanol 2b in aqueous solutions at different pH values was studied by ESI-MS experiments. In addition, the pharmacological profiles of the C/Si analogues trifluperidol (2a) and sila-trifluperidol (2b) and of the related compounds haloperidol (la) and sila-haloperidol (lb) were studied in functional receptor assays at human dopamine DI and D, receptors. Sila-substitution of la ( lb) and 2a ( 2b) affects the pharmacological properties significantly.
查看更多